Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograft

SP Govek, JY Nagasawa, KL Douglas, AG Lai…

文献索引：WO2013/142266 A1, ;

全文：HTML全文

被引用次数: 2

摘要

Selective estrogen receptor degraders (SERDs) have shown promise for the treatment of ER+ breast cancer. Disclosed herein is the continued optimization of our i.